UBX

Unity Biotechnology

Delisted

UBX was delisted on the 8th of July, 2025.

40 hedge funds and large institutions have $5.87M invested in Unity Biotechnology in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

5% less funds holding

Funds holding: 4240 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

30% less capital invested

Capital invested by funds: $8.4M → $5.87M (-$2.53M)

Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$71K
Puts
$23K
Net Calls
Net Calls Change

Top Buyers

1 +$113K
2 +$73.7K
3 +$39.8K
4
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$29.3K
5
Squarepoint
Squarepoint
New York
+$22.9K

Top Sellers

1 -$1.33M
2 -$199K
3 -$59.2K
4
Jane Street
Jane Street
New York
-$54.9K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$49.2K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.65M
2
$1.51M
3
$914K
4
$220K
5
$203K
6
$184K
7
$175K
8
$153K
9
$115K
10
$82K
11
$80.6K
12
$71.4K
13
$67.6K
14
$62K
15
$61.8K
16
$61.4K
17
$40K
18
$37K
19
$29.3K
20
$27K
21
$22.9K
22
$22.1K
23
$21.5K
24
$17.4K
25
$17.1K